期刊文献+

曲美他嗪治疗高血压合并糖尿病左室舒张功能不全的临床研究 被引量:1

下载PDF
导出
摘要 目的观察曲美他嗪对高血压合并糖尿病左室舒张功能不全的改善作用。方法将58例高血压合并糖尿病左室舒张功能不全随机分为两组,分别予以基础治疗(对照组)和加用曲美他嗪(观察组),治疗12周后观察其左室射血分数(LVEF)、左室舒张末期容积(EDV)、左室收缩末期容积(ESV)以及临床疗效。结果与对照组相比,观察组能明显的提高总有效率(79.49%】69.23%),改善LVEF、EDV、ESV,进而改善高血压合并糖尿病左室舒张功能不全的临床症状。结论曲美他嗪可增加高血压合并糖尿病左室舒张功能不全心肌的收缩力,提高心排血量。 Objective To observe trimetazidine on the improvement of hypertension and diabetes left ventricular diastolic dysfunction role.Methods 58 cases of hypertension and diabetes left ventricular diastolic dysfunction were randomly divided into two groups,respectively,be the basis of treatment(control group) and with trimetazidine(study group) was observed after 12 weeks of treatment,left ventricular ejection fraction(LVEF),left ventricular end-diastolic volume(EDV),left ventricular contraction to the end of the volume(ESV),and clinical efficacy.Results compared with the control group,the observation group can significantly improve the overall efficiency(79.49% vs.69.23%),improve LVEF,EDV and ESV,thereby improving the clinical symptoms of hypertension and diabetes left ventricular diastolic dysfunction.Conclusion Trimetazidine triazine can increase the treatment hypertension and diabetes left ventricular diastolic dysfunction,myocardial contractility and improve cardiac output and improve clinical symptoms.
作者 刘伟
出处 《中国保健营养(下半月)》 2012年第7期2780-2781,共2页 China Health Care & Nutrition
关键词 曲美他嗪 高血压 糖尿病左室舒张功能不全 Trimetazidine diabetes hypertension left ventricular diastolic dysfunction
  • 相关文献

参考文献8

二级参考文献33

  • 1张之亮,马俊爱.曲美他嗪治疗冠心病心力衰竭的临床观察[J].中国心血管杂志,2006,11(4):301-303. 被引量:38
  • 2阎爱国,蒋晓辉,朱凤雯.曲美他嗪联合卡维地洛治疗老年充血性心力衰竭临床观察[J].中国心血管杂志,2006,11(5):365-367. 被引量:5
  • 3Mody FV,Singh BN, Mohiuddin IH,et al. Trimetazidine-induced enhancement of myocardial glucose utilizating in normal and ischemic myocardial tissue: an evaluation by positron emission tomography. Am J Cardiol, 1998,82:42K-49K.
  • 4Kantor PF, Lucien A, Kozak R, et al. The antianginal drug trimetazidine shifts cardiac energy metabolism from fatty acid oxidation to glucose oxidation by inhibiting mitochondiral long-chain 3- ketoacyl eoenzyme A thiolase. Cire Res,2000,86:580-588.
  • 5Renaud JF. Internal pH, Na^+ and Ca^2 + regulation by trimetazidine during cardiac cell acidosis. Cardiovasc Drug Ther, 1988, 1:677-686.
  • 6[2]Hanna Szwed, Robert Pachocki, Malgorzata Domzal-Bochenska, et al. Efficacy and tolerance of trimetazidine combination with a conventional antianginal drug in pations with stable effort angina. Diaagpmpsos and Treatment in Cardiology, 1997, 4: 237.
  • 7[3]Chunzeng LU, Pawel Dabrowski, Gabriele Fragasso, et al. Effects of trimetazidine on ischemic left ventricular dysflmction in patients with coronary artery disease. American Journal of Cardiology, 1998, 82.
  • 8[4]Brotier L, Barat JL, Combe C, et al. Therapeutic value of a cardioprotective agent in patients with severe ischaemic cardiomyopathy. Eur Hur Heart J, 1990, 11: 207.
  • 9[5]Shlyakhto EV, Vakhrameyeva IV, Nifontoff EM, et al. Chriomic effects of myocarcdial cytoprotector trimetazidine for CAD: clincal, biochemical and echocardiographical follow-up[abstract]. Eur Heart J, 1998, 19 Abstract (suppl): 191.
  • 10Lopaschuk GD. Treating ischemic heart disease by pharmacologically improving cardiac energy metabolism. Presses Med. 1998, 27:2100.

共引文献18

同被引文献1

  • 1唐来荣.用硝苯地平缓释片联合马来酸依那普利及吲达帕胺对高血压合并糖尿病患者进行降压治疗的效果观察[J].当代医药论丛,2014(4):257-258.

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部